Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® E. Coli specialty page provides E.coli-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

E. COLI VIDEOS - Page 1

Observing Microbiome Changes After Single-Dose Antibiotics for Traveler's Diarrhea
Mark Riddle, MD, DrPH, speaks to Contagion at ACG 2019 about the results of a study looking into microbiome changes associated with single-dose antibiotics for the treatment of traveler's diarrhea.
Lack of Agreement Between Fosfomycin Susceptibility Testing Methods Against <i>Pseudomonas</i>
Elizabeth Hirsch, PharmD, and Elizabeth Smith, PharmD candidate, discuss fosfomycin susceptibility testing.
<i>Escherichia coli</i> ST131: Prevalence, Resistance, and Virulence in Boston vs Minneapolis
Elizabeth Hirsch, PharmD, and Mélanie Mahoney, PharmD candidate, discuss their poster on Escherichia coli ST131 in Boston vs Minneapolis at ECCMID 2019.
Addressing Issues Surrounding Current Antibiotic Development
James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.
What's Surprising About the Discovery of MCR1_NJ?
Barry Kreiswirth, PhD, founding director, Public Health Research Institute Tuberculosis Center, professor of medicine at Rutgers University, discusses the implications of the findings of his study.
 
How Should Practitioners Test for the Colistin-Resistant mcr-1 Gene?
Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, discusses how practitioners should test for colistin-resistant pathogens.
What Pathogens Are Most Affected by the Colistin-Resistant mcr-1 Gene?
Prof. Andrea Endimiani, MD, PhD, from the Institute of Infectious Diseases at the University of Bern, Switzerland, explains which pathogens are most affected by the colistin resistant mcr-1 gene.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?